NGAL has also been linked to sepsis severity and mortality in prior studies, suggesting that it may serve best as a complementary biomarker within a broader panel rather than as a standalone predictor, particularly when it is interpreted alongside organ dysfunction scores and endothelial injury markers such as SDC1 [23,24]. This evidence concerns the gene LCN2 and Sepsis.